amiodarone has been researched along with edoxaban in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Antman, EM; Atar, D; Braunwald, E; Camm, AJ; Giugliano, RP; Heidbuchel, H; Murphy, SA; Ruff, CT; Steffel, J | 1 |
| Conen, D | 1 |
| Aiuchi, N; Kinjo, T; Nakagawa, J; Niioka, T; Tomita, H; Ueno, K | 1 |
1 trial(s) available for amiodarone and edoxaban
| Article | Year |
|---|---|
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Female; Hemorrhage; Humans; Male; Middle Aged; Pyridines; Stroke; Thiazoles; Treatment Outcome; Warfarin | 2015 |
2 other study(ies) available for amiodarone and edoxaban
| Article | Year |
|---|---|
Edoxaban and amiodarone: interactions on multiple levels.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Female; Humans; Male; Pyridines; Thiazoles; Warfarin | 2015 |
Associations among Plasma Concentrations of Edoxaban and M-4, Prothrombin Time, and the SLCO1B1*15 Haplotype in Patients With Nonvalvular Atrial Fibrillation.
Topics: Amiodarone; Atrial Fibrillation; Haplotypes; Humans; Liver-Specific Organic Anion Transporter 1; Prothrombin Time | 2023 |